News Sentiment

NSPR sentiment intelligence

InspireMD Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.72 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+3.0% over one week, -1.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 3.0% Price confirming higher
Trend fit Trend inactive -1.4% over four weeks
Fair value -70.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 47
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 8
TradingView 6
TradingKey 6
GlobeNewswire 4
Motley Fool 3
dars.gov.et 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Earnings 26
Market update 26
Analyst action 2
Regulatory and legal 2
Deals and strategy 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
The Globe and Mail Direct company coverage

InspireMD NSPR Q1 2026 Earnings Transcript

InspireMD (NASDAQ:NSPR) reported robust 122% revenue growth in Q1 2026, primarily driven by the U.S. launch of CGuard Prime and international expansion. However, the company voluntarily paused U.S. commercialization of its CGuard Prime 135 delivery system due to technical feedbac

Tone
Negative 38/100
Event
Earnings
Published
01 Jun 2026 22:10
Source
The Globe and Mail
Investing.com South Africa Direct company coverage

InspireMD director Paul Stuka buys $17,500 in shares By Investing.com

InspireMD director Paul Stuka recently purchased 20,000 shares of the company's common stock for $17,500, with shares acquired at a weighted average price of $0.8750. This transaction increases his direct holdings to 667,871 shares, occurring while the stock is near its 52-week l

Tone
Neutral 50/100
Event
Market update
Published
29 May 2026 21:40
Source
Investing.com South Africa
Investing.com Direct company coverage

InspireMD director Paul Stuka buys $17,500 in shares

InspireMD director Paul Stuka purchased 20,000 shares of the company's common stock for $17,500 on May 27, 2026, when the stock was near its 52-week low. This insider buy comes despite the company facing unspecified operational challenges, although it recently exceeded Q1 2026 an

Tone
Positive 65/100
Event
Market update
Published
29 May 2026 20:40
Source
Investing.com